Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Huo

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
European Journal of Radiology|February 22, 2022
A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancerJorge E Jimenez, Abeer Abdelhafez, Elizabeth A Mittendorf, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Academic Radiology|July 17, 2021
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRosalind P Candelaria, David A Spak, Gaiane M Rauch, et al.
Future Oncology (London, England)|September 14, 2021
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in ChinaYu Wang, Jianmin Zhang, Wenbin Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancerDi Ai, Jun Yao, Fei Yang, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Journal of the National Cancer Institute|April 15, 2016
miR-141-Mediated Regulation of Brain Metastasis From Breast CancerBisrat G Debeb, Lara Lacerda, Simone Anfossi, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
European Journal of Radiology|February 22, 2022
A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancerJorge E Jimenez, Abeer Abdelhafez, Elizabeth A Mittendorf, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Academic Radiology|July 17, 2021
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRosalind P Candelaria, David A Spak, Gaiane M Rauch, et al.
Future Oncology (London, England)|September 14, 2021
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in ChinaYu Wang, Jianmin Zhang, Wenbin Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancerDi Ai, Jun Yao, Fei Yang, et al.
Breast Cancer Research and Treatment|June 1, 2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trialKamaria L Lee, Clinton Yam, Li Zhao, et al.
Journal of the National Cancer Institute|April 15, 2016
miR-141-Mediated Regulation of Brain Metastasis From Breast CancerBisrat G Debeb, Lara Lacerda, Simone Anfossi, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Pageof 23